Summary
Updated Aug 31, 2026
Lawrence Waldman is Director of Apyx Medical Corp (APYX). 5 SEC Form 4 filings on record going back to 2024, most recently on 2 July 2026.
Recent Transactions
3Every recent SEC Form 4 transaction Lawrence Waldman has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Lawrence Waldman go back to 2024: 5 primary Form 4 filings, an average of 1.7 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Sector
No other insider has filed at Lawrence Waldman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- RA CAPITAL MANAGEMENT, L.P. - $83.13M of VOR open-market activity in the last 12 months
- Matthew Rabinowitz - $82.72M of NTRA open-market activity in the last 12 months
- Mark T. Bertolini - $82.60M of OSCR open-market activity in the last 12 months
- Frank Torti - $82.04M of ROIV open-market activity in the last 12 months
- ILLUMINA, INC. - $79.85M of GRAL open-market activity in the last 12 months
- Darren M. Black - $77.56M of LFST open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Lawrence Waldman?
Lawrence Waldman is a corporate insider, tracked as Director of Apyx Medical Corp (APYX). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Lawrence Waldman submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Lawrence Waldman's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Lawrence Waldman and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial